USPTO serial 97490372
QUARRIUS BY OSR
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- JOHN, CRISTEL M
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with QUARRIUS BY OSR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cheryl L. Burbach
Cheryl L. Burbach HOVEY WILLIAMS LLP10801 Mastin Blvd., Suite 1000Overland Park, KS 66210United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software for use in the fields of pharmaceuticals, medical devices, healthcare, biotechnology, regulatory compliance, and other industries, namely, software for digitalizing, searching, annotating, archiving, discussing, extracting, and organizing documents and information submitted to, and issued by, regulatory authorities; Downloadable software for use in the pharmaceutical, healthcare, biotechnology, and other industries, namely, software for providing a solution to digitize documents and information submitted to and issued by pharmaceutical- and health-related regulatory authorities, and other regulatory authorities; Downloadable software for use in the pharmaceutical, healthcare, biotechnology, and other industries, namely, software for providing a search engine for documents and information submitted to and issued by pharmaceutical- and health-related regulatory authorities, and other regulatory authorities; Downloadable software for use in the pharmaceutical, healthcare, biotechnology, and other industries, namely, software for providing annotation, archiving, and discussion forum services for documents and information submitted to and issued by pharmaceutical- and health-related regulatory authorities, and other regulatory authorities; Downloadable software for use in the pharmaceutical, healthcare, biotechnology, and other industries, namely, software for providing a solution to extract and organize information from documents and information submitted to and issued by pharmaceutical- and health-related regulatory authorities, and other regulatory authorities | ACTIVE | — |
| 035 | Advertising and promotional services for others in the fields of pharmaceuticals, biotechnology, healthcare, medical devices, and other fields; Providing business intelligence services in the fields of pharmaceuticals, biotechnology, healthcare, medical devices, and other fields | ACTIVE | — |
| 042 | Providing online, non-downloadable software for use in the fields of pharmaceuticals, medical devices, healthcare, biotechnology, regulatory compliance, and other industries, namely, providing software for digitalizing, searching, annotating, archiving, discussing, extracting, and organizing documents and information submitted to, and issued by, regulatory authorities; Providing online, non-downloadable software services for use in the field of pharmaceuticals, medical devices, healthcare, biotechnology, regulatory compliance, and other industries, namely, providing a software solution to digitalize documents and information submitted to and issued by pharmaceutical and health- related regulatory authorities, and other regulatory authorities; Software as a service (SaaS) services featuring software for use in the pharmaceutical, healthcare, biotechnology, and other industries, namely, providing software for allowing search engine for documents and information submitted to and issued by pharmaceutical and health-related regulatory authorities, and other regulatory authorities; Software as a service (SaaS) services featuring software for use in the pharmaceutical, healthcare, biotechnology, and other industries, namely, providing software for allowing annotation, archiving, and discussion forum services for documents and information submitted to and issued by pharmaceutical and health-related regulatory authorities, and other regulatory authorities; Software as a service (SaaS) services featuring software for use in the pharmaceutical, healthcare, biotechnology, and other industries, namely, providing a software solution to extract and organize information from documents and information submitted to and issued by pharmaceutical and health-related regulatory authorities, and other regulatory authorities | ACTIVE | — |
| 045 | Regulatory and legal compliance consulting in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, and other fields; Providing information about legal eligibility requirements for government medical and pharmaceutical programs | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PROPHARMA GROUP HOLDINGS, LLC
- Other trademarks owned by OneSource Regulatory, LLC
- Other trademarks owned by OneSource Regulatory, LLC
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named QUARRIUS BY OSR
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 26, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 26, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 24, 2024 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jan 16, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 12, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 12, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 12, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 26, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 26, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 26, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 26, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 26, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 25, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 30, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 30, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 10, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 26, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 20, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 25, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 9, 2022 | NWAP | NEW APPLICATION ENTERED | — |